Melatonin reorganizes the cell's internal architecture, not just neutralizing damage
En los laboratorios de Granada y Lyon, investigadores han descubierto que la melatonina —conocida durante décadas como la hormona del sueño— posee una capacidad más profunda: la de reparar los puentes de comunicación entre las estructuras internas de la célula que se deterioran en la obesidad y la diabetes tipo 2. Este hallazgo, publicado en Cell Communication and Signaling, invita a reconsiderar el papel de una molécula familiar, recordándonos que la naturaleza guarda secretos incluso en lo que creemos conocer bien. La ciencia avanza aquí no hacia algo nuevo, sino hacia una comprensión más honesta de algo antiguo.
- La obesidad y la diabetes tipo 2 no solo alteran el peso o el azúcar en sangre: destruyen silenciosamente los puentes de comunicación entre las centrales energéticas de cada célula, desencadenando inflamación y daño metabólico en cadena.
- Investigadores de las universidades de Granada y Lyon demostraron en modelos animales que la melatonina restaura esas estructuras dañadas —llamadas MAMs— y revive el diálogo entre mitocondrias y retículo endoplasmático.
- El hormona redujo el estrés oxidativo, equilibró los niveles de calcio celular y evitó la liberación de moléculas asociadas a la muerte celular, con mejoras medibles en la forma en que las células procesan la energía.
- El descubrimiento reposiciona a la melatonina: ya no es solo un regulador del sueño o un antioxidante, sino un modulador de la arquitectura celular con potencial terapéutico para enfermedades metabólicas.
- El camino hacia aplicaciones clínicas aún requiere ensayos en humanos que confirmen si estas mejoras celulares se traducen en beneficios reales y seguros para los pacientes.
Investigadores de las universidades de Granada y Lyon han identificado una función desconocida de la melatonina: su capacidad para reparar una forma crítica de comunicación celular que se deteriora en la obesidad y la diabetes tipo 2. El estudio, publicado en Cell Communication and Signaling, abre nuevas perspectivas sobre una hormona que durante décadas fue considerada principalmente un regulador del sueño.
Dentro de cada célula, las mitocondrias —generadoras de energía— y el retículo endoplasmático —centro de producción y distribución de proteínas y lípidos— se comunican a través de estructuras dinámicas llamadas MAMs. En personas con obesidad y diabetes tipo 2, estos puentes se deterioran, provocando estrés oxidativo, inflamación y una cascada de fallos metabólicos. El equipo liderado por el profesor Ahmad Agil administró melatonina de forma crónica en modelos animales de ambos sexos y comprobó que la hormona restauraba la integridad de esos puentes, equilibraba el calcio intracelular, reducía el daño oxidativo a lípidos esenciales como la cardiolipina y prevenía la liberación de citocromos asociados a la muerte celular.
Lo que distingue este hallazgo de investigaciones anteriores es su profundidad: la melatonina no actúa solo como antioxidante, sino como reorganizadora de la arquitectura interna de la célula. El estudio se centró en el músculo esquelético, clave en el consumo de energía y la regulación del azúcar en sangre, lo que refuerza su relevancia metabólica.
La melatonina es producida naturalmente por el cerebro durante la noche y se comercializa como suplemento para el insomnio, aunque se recomienda supervisión médica. Este trabajo sugiere que su potencial va mucho más allá. El siguiente paso serán ensayos clínicos en humanos para confirmar si estas mejoras celulares se traducen en beneficios reales y para establecer protocolos de suplementación seguros. Por ahora, el estudio es una prueba de concepto convincente: una hormona familiar puede guardar profundidades que apenas comenzamos a comprender.
Researchers at the universities of Granada and Lyon have identified a previously unknown way that melatonin—the hormone best known for regulating sleep—might shield the body against a dangerous combination of obesity and type 2 diabetes. The discovery, published in Cell Communication and Signaling, centers on how melatonin repairs a critical form of cellular communication that breaks down in metabolic disease.
Inside every cell, two vital structures normally work in tandem. Mitochondria function as the cell's power plants, generating the energy needed for all biological processes. The endoplasmic reticulum acts as the cell's manufacturing and distribution center, producing and transporting proteins and lipids throughout the cell. These two organelles are connected by specialized bridges called MAMs—dynamic structures that allow rapid exchange of signals and molecules between them. In healthy cells, this conversation flows smoothly. But in people with obesity and type 2 diabetes, these bridges deteriorate, triggering oxidative stress, inflammation, and a cascade of metabolic failures.
The Granada-Lyon team, led by pharmacology professor Ahmad Agil, tested chronic melatonin administration in animal models of both sexes. They found that the hormone restored the integrity of these damaged bridges and revived functional communication between the two organelles. The results showed melatonin improved mitochondrial health, balanced calcium levels within cells, reduced oxidative damage to critical lipids like cardiolipine, and prevented the release of cytochrome c—a molecule linked to cell death. Taken together, these effects translated into measurable improvements in how cells process energy.
Melatonin is produced naturally by the brain, primarily at night, where its main job is orchestrating the sleep-wake cycle. It rises with darkness and falls with light, which is why screens, stress, and jet lag can disrupt it. Beyond its role as a biological timekeeper, the hormone is also sold as a supplement for insomnia and sleep disorders, though medical supervision is recommended. Until now, scientists understood melatonin's antioxidant properties—its ability to neutralize harmful molecules. This new work reveals something deeper: melatonin can reorganize the internal architecture of cells and optimize how their component structures communicate with one another.
The research focused on skeletal muscle, an organ critical for energy consumption and blood sugar regulation. Agil explained that the findings allow scientists to understand melatonin's action at the subcellular level, not merely as an antioxidant but as a modulator of cellular architecture and inter-organelle communication. That distinction matters because it opens new therapeutic avenues. The damaged bridges between mitochondria and endoplasmic reticulum are exquisitely sensitive to metabolic changes, stress, and disease—and now researchers have evidence that melatonin can mend them.
The work represents a shift in how scientists think about melatonin's potential. For decades, the hormone was pigeonholed as a sleep aid. This study suggests it may have far broader metabolic applications, particularly for the growing population struggling with obesity and type 2 diabetes. The next step will be human trials to confirm whether these cellular-level improvements translate into clinical benefit and to establish safe supplementation protocols. Until then, the findings remain a proof of concept—compelling evidence that a hormone we've known for generations may have hidden depths.
Notable Quotes
These results allow us to understand how melatonin acts at the subcellular level, not only as an antioxidant but as a modulator of cellular architecture and communication between organelles, opening new therapeutic possibilities.— Ahmad Agil, pharmacology professor at the University of Granada
The Hearth Conversation Another angle on the story
So melatonin repairs these bridges between mitochondria and the endoplasmic reticulum. Why does that matter so much?
Because when those bridges break down—which happens in obesity and diabetes—the cell loses its ability to communicate efficiently. Energy production falters, calcium gets out of balance, and oxidative damage accumulates. It's like a factory where the power plant and the assembly line stop talking to each other.
And melatonin fixes that?
In these animal models, yes. Chronic melatonin administration restored the bridges and improved how cells processed energy. But that's the key word—chronic. This wasn't a one-time dose.
Does this mean people should start taking melatonin supplements for diabetes?
Not yet. This is animal research. We don't know if the same mechanism works in human bodies, or what dose would be safe and effective. That's the honest answer.
What surprised the researchers most?
That melatonin does more than just neutralize harmful molecules. It actually reorganizes the cell's internal structure and restores communication between different parts. That's a different kind of action than they expected.
Why focus on skeletal muscle?
Because it's where the body burns most of its energy and where it regulates blood sugar. If you want to understand metabolic disease, that's where you look.